simulating fundamental connections and validating applications. One of the

researches was focussed on the principles governing the development of highly

complex brains, as well as their interactions with other body parts. Combining

fundamental pharmacological approaches to degenerative diseases with an under-

standing of the brain’s structure and drug interactions can result in a pharmacological

approach to degenerative disorders. It is being developed by mimicking the central

nervous system with pluripotent human cells that maintain an intact blood-brain

barrier. A portion of the procedure was focussed on the interaction of human foetal

stem cells with an adult mouse model. Then, in neuro-oncology studies, a chemo-

tactic gradient was used.

A proof of concept in Alzheimer’s disease has been done on a chip neuro-

spheroids, in a flow-controlled environment. The results were recorded, both before

and after blood flow. The research studies suggested that dynamic conditions

encouraged the growth of neurons. There was another group who had been success-

ful in constructing a brain-on-a-chip, mimicking the characteristics of the brain.

They used both the electrodes that measure changes in a specific brain region as well

as all that region’s network activity to make a representation of disease in the

research of new molecule (Bang et al. 2019).

6.6.7

Heart-on-a-Chip

Cardiovascular in vitro models typically establish a monolayer soft tissue within a

complex geometry under static conditions. The tissue forms a flat layer with random

cell alignment, no movement, and a physiological state that is not present in vivo. At

the start of ‘heart-on-chip’ studies, similar situations were applied, but the physiol-

ogy gradually progressed. A system that uses ‘micro-engineered cardiac tissues’

(ECTs) to sustain a 3D beating development that helps up of human cardiomyocytes

is an innovation. There was a high degree of coupling in both the mechanical and

electrical responses. The platform stimulated the cells mechanically during culture,

promoting maturation and increasing mechanical and electrical pairing. The device

was also used to measure the amounts of various isoprenalines. Cell proliferation

with high alignment and morphology was aided by the interaction of oxygenation

conditions and exosystemic geometry.

Engineered nanomaterials were used to create a 3D chip influenced by mussels to

assess cardiac contractility. The extracellular matrix was made from gelatin, titanium

oxide, and silver nanoparticles. In vitro, the method allowed investigators to measure

the contractile effects of nanoparticle cardiotoxicity on sarcomere calcium signal-

ling. A 48-h test has been used as anti-pharmacological quality control assay.

Preclinical trials were also used to compare the efficacy and safety of the drug in

this case. An ‘Integrated Heart/Cancer on a Chip’ (iHCC) was created using human

cells. To simulate heart dynamics and evaluate the anticancer drug doxorubicin, the

microfluidic sensor was outfitted with a micropump and hydraulic valves (Kamei

et al. 2017).

6

Organ-on-a-Chip: Novel In Vitro Model for Drug Discovery

87